Alton Telegraph on MSN
Johnson & Johnson to buy Firefly Bio for $1 billion to boost cancer drugs
Johnson & Johnson will buy Firefly Bio for $1 billion, adding its Firelink platform to target KRAS-driven cancer tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results